ABOUT US

Our Mission

To design and build engineered protein therapeutics with our AI-native platform, transforming what’s possible in immune-mediated disease treatment.

Our Vision

To establish AI-designed proteins as a foundational therapeutic modality and bring these novel biologics to patients.

Who We Are

Evozyne brings together leaders in AI, high-throughput biology, immunology, and drug development. The company was founded by Paragon Biosciences to advance its validated AI-native platform and a growing pipeline of engineered proteins designed for real clinical impact.